Our tests

Maternal serum screening is a blood test available to pregnant women who want to know their chance of having a baby with a chromosome condition, such as Down syndrome. Serum screening can also provide additional information about pregnancy health, such as the risk of developing early-onset pre-eclampsia.

Diagnostic testing for the identification of chromosome changes that affect normal fetal development.

Newborn bloodspot screening is an extremely successful public health program which identifies babies that may have rare but significant medical conditions.

Metabolic disorders are a group of serious medical conditions caused by abnormal levels of metabolites in the blood or urine. This can be toxic and affect normal development.

The usefulness of genetic testing for degenerative neurogenetic conditions depends on the condition. While the genetic basis of some neurological conditions is well understood, the basis of others is not. Some of the more common neurogenetic conditions, such as Alzheimer disease or Parkinson disease, have subsets with a clear genetic cause, while the cause of other cases is unknown.

Disorders/Differences of Sex Differentiation (DSD) are conditions where the development of chromosomal, anatomical or gonadal sex is atypical. DSD covers a wide spectrum of disorders such as hypospadias (misplacement of the urethral opening on the penis), premature ovarian insufficiency and complete sex reversal (where the physical sex does not match the genetic sex of an individual).

Identification of genetic causes of cardiac disorders can be lifesaving. Establishing a genetic cause for such conditions can affect further patient testing, management and surveillance. This information can also be important for immediate family members, who may be at risk of developing heart problems.

A chromosome microarray is a powerful tool used to look at genetic changes that affect health or development. Using high density SNP based technology allows for the identification of a larger number of genetic conditions.

Spinal Muscular Atrophy Carrier Screening

This test is a genetic screen to identify if you are a carrier of spinal muscular atrophy.

You must have a completed doctors request form to order this test online.

Cost

The cost of this test is AUD$220.00. No Medicare rebate available.

Spinal muscular atrophy carrier screening is available as a single test to order and pay online.

Cystic Fibrosis Carrier Screening & Diagnostic

This test is a genetic screen to identify if you are a carrier of cystic fibrosis and is available to order and pay online.

You must have a completed doctors request form to order this test.

Cost

The cost of this test is AUD$212.50.

Medicare eligibility

Patients may be eligible for a Medicare rebate, if:

Choose VCGS for comprehensive genetic testing and support services for a large range of single gene disorders including cystic fibrosis, fragile X syndrome, ataxias and hearing loss.

Mitochondria are known as our body's power plants. They burn the sugars, fats and proteins in our diet to generate the energy that our body needs to function normally. When our mitochondria don't function correctly this can impact our health.

VCGS provides a comprehensive range of diagnostic genetic testing for childhood cancers and has led the development of an advanced test for monitoring bone marrow and organ transplants.